Curran Terrie
Arcutis Biotherapeutics, Inc. - Common stock · Director
Curran Terrie is listed in public filings as director. This Curran Terrie insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Arcutis Biotherapeutics, Inc. - Common stock (ARQT), and Phathom Pharmaceuticals, Inc. (PHAT). Investors use Curran Terrie's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $278k20.6k shares | Grant / ExerciseJun 12, 2025 | $277.7K20.6k shares | $13.50 | -- | |
| --17.7k shares | Grant / ExerciseJun 12, 2025 | Disclosure amount unavailable7.6k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.0M342.5k shares | Grant / ExerciseFeb 27, 2025 | $2.0M342.5k shares | $5.76 | -- | |
| $2.4M360.5k shares | SellJan 21, 2025 | $125.9K19.1k shares | $6.59 | -- | |
| $110k10.1k shares | SellNov 11, 2024 | $94.2K8.7k shares | $10.85 | -- | |
| $4.4M377.7k shares | SellJul 15, 2024 | $396.7K33.8k shares | $11.72 | -- | |
| $233k27.1k shares | Grant / ExerciseJun 14, 2024 | $233.5K27.1k shares | $8.63 | -- | |
| --18.8k shares | Grant / ExerciseJun 14, 2024 | Disclosure amount unavailable10.1k shares | -- | -- |